(Q47354181)

14 January 2018

title

Effect of pulse dexamethasone therapy on the incidence and severity of chronic lung disease in the very low birth weight infant (English)

1 reference

14 January 2018

1 reference

1 reference

1 reference

Brozanski BS

1

1 reference

14 January 2018

Jones JG

2

1 reference

14 January 2018

Gilmour CH

3

1 reference

14 January 2018

Balsan MJ

4

1 reference

14 January 2018

Vazquez RL

5

1 reference

14 January 2018

Israel BA

6

1 reference

14 January 2018

Newman B

7

1 reference

14 January 2018

Mimouni FB

8

1 reference

14 January 2018

Guthrie RD

9

1 reference

14 January 2018

language of work or name

English

0 references

publication date

1 May 1995

1 reference

14 January 2018

The Journal of Pediatrics

published in

1 reference

14 January 2018

volume

126

1 reference

14 January 2018

issue

5 Pt 1

1 reference

14 January 2018

page(s)

769-776

1 reference

14 January 2018

Effect of dexamethasone on pulmonary inflammation and pulmonary function of ventilator-dependent infants with bronchopulmonary dysplasia

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970410-8

A controlled trial of dexamethasone in preterm infants at high risk for bronchopulmonary dysplasia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970410-8

Dexamethasone treatment in preterm infants at risk for bronchopulmonary dysplasia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970410-8

Randomized controlled trial of dexamethasone treatment in very-low-birth-weight infants with ventilator-dependent chronic lung disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970410-8

Hypertrophic cardiomyopathy associated with dexamethasone therapy for chronic lung disease in preterm infants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970410-8

Dexamethasone in neonatal chronic lung disease: pulmonary effects and intracranial complications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970410-8

Controlled trial of dexamethasone therapy in infants with bronchopulmonary dysplasia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970410-8

Two doses of early intravenous dexamethasone for the prevention of bronchopulmonary dysplasia in babies with respiratory distress syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970410-8

Alveolar macrophage status in bronchopulmonary dysplasia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970410-8

Tumour necrosis factor in the bronchoalveolar secretions of infants with the respiratory distress syndrome and the effect of dexamethasone treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970410-8

10.1016/S0022-3476(95)70410-8

7 January 2021

Identifiers

DOI

1 reference

14 January 2018

1 reference

14 January 2018